e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap
Iwamoto Hiroshi, Gao Jing, Koskela Jukka, Kinnula Vuokko, Kobayashi Hideo, Laitinen Tarja, Mazur Witold
Source:
Eur Respir J 2014; 43: 421-429
Journal Issue:
February
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Iwamoto Hiroshi, Gao Jing, Koskela Jukka, Kinnula Vuokko, Kobayashi Hideo, Laitinen Tarja, Mazur Witold. Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap. Eur Respir J 2014; 43: 421-429
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Sputum biomarkers in COPD exacerbations
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011
Changes in the induced sputum proteome during COPD exacerbations
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020
Sputum neutrophilic markers in asthma of varying severity and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 550s
Year: 2003
Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Blood biomarkers in asthma and COPD
Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease
Year: 2017
COPD assessment test correlation with the increase of the inflammatory markers in COPD exacerbations
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011
Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
COPD and asthma overlap with bronchiectasis
Source: Eur Respir Monogr 2018; 81: 167-185
Year: 2018
Relationship of blood eosinophil count to exacerbations in COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Pulmonary biomarkers in asthma and COPD
Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
Year: 2007
Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients.
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018
Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 95s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept